换一批
换一批摘要A mutant HSV(mtHSV) deleted icp34.5,an apoptosis-inhibiting gene was constructed. It is supposed that the mtHSV can replicate in p53-deficient cells selectively and lead to oncolysis targetedly. Mice tumor model harboring sarcoma cell line s-180 was developed and the mtHSV was injected into the tumors. We found that the mean volume and weight of tumors of early therapeutic group(ETG) were reduced 49.29% and 38.31% of that of control tumors.In the mid-term group(MTG),the redutcion rate were 26.9% and 24.52% respectively.
更多相关知识
- 浏览2
- 被引1
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
